Ronan O'Connor

Respiratory Motion, Inc. develops medical devices. The firm specializes in clinical research, clinical evaluation and testing. Its product ExSpiron 1Xi, measures minute ventilation non-invasively. The company was founded by Jenny E. Freeman, Alexander Panasyuk and Svetlana Panasyuk in March 2010 and is headquartered in Waltham, MA.

MedNova Ltd. manufactures medical devices. The company specializes in the development of minimally-invasive vascular products for the protection and repair of the heart, brain and blood vessels. It was founded in 1996 and is headquartered in Galway, Ireland.

Otsuka Medical Devices Co., Ltd. engages in medical equipment business focusing on therapeutic devices. Its devices include ultrasound-based renal denervation, drug device combinations, and novel solutions for drug-refractory patients and intractable diseases. The company was founded on February 15, 2011 and is headquartered in Tokyo, Japan.

ReCor Medical, Inc. develops novel therapeutic ultrasound catheter technologies The firm develops a therapeutic non-focused ultrasound system for performing renal denervation in patients with resistant hypertension. The company was founded by Mano Iyer and Jacques Seguin in July 2009 and is headquartered in Palo Alto, CA.

Brightwater Medical, Inc. develops medical devices. It offers ConvertX Stent, a device that can be converted from a catheter to a nephroureteral stent without a second interventional procedure. The company was founded by Bob Smouse in January 2014 and is headquartered in Temecula, CA.

Vasorum Ltd. engages in the research and development of medical equipment. The firm offers Celt ACD, a closure device for cardiology and radiology operations. The company was founded by James Coleman, Christopher Cummins, and Robert Perryman and is headquartered in Leinster, Ireland.

Part of Otsuka Holdings Co., Ltd., Otsuka Medical Devices UK Ltd. is a company that functions as an investment holding company. The company is based in Oxford, UK and was founded in 2018.

Veryan Medical Ltd. develops and commercializes novel vascular stent technology. The firm's products are designed to clinical performance and bio-mechanical performance of stented vessels. The company was founded by Colin G. Caro, Charles Richard Taylor and Paul Burke Gilson in 2003 and is headquartered in Oxford, the United Kingdom.